Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Steve Harr

Steve Harr

individual
Ecosystem influencer

About

Steve Harr, M.D., is co-founder, President, and Chief Executive Officer of Sana Biotechnology, a cell and gene engineering company. Before Sana, he was Chief Financial Officer and Head of Corporate Development at Juno Therapeutics and earlier spent 12 years at Morgan Stanley, including as Managing Director and Head of Biotechnology Investment Banking. Sana's official bio also notes prior board roles at Loxo Oncology and JW Therapeutics.

Areas of interest

biotechcell therapygene therapygene editingimmunologyoncologytype 1 diabetesregenerative medicinecorporate finance